New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology. To read more.
Recent Posts
- Join NJ ACTS Genetically informed Research, Education, And Treatment (GREAT) Core TODAY at 10:30 am
- A Common Antihistamine Shows Promise in Treating Liver Complications of a Rare Disease.
- NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) Workshop Series on 2/20
- Collaboration Between NJIT, Rutgers, Temple Adds Security to AI Education.
- Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity.
Categories
- Community (2,133)
- Covid (981)
- CTO Events (6)
- News (2,722)
- Pilots (21)